• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性乳腺癌中 TCOF1 的上调促进了肿瘤干细胞特性和肿瘤生长,并与不良预后相关。

TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis.

机构信息

Tung Biomedical Sciences Centre, Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong.

City University of Hong Kong Shenzhen Research Institute, Shenzhen, China.

出版信息

Br J Cancer. 2022 Jan;126(1):57-71. doi: 10.1038/s41416-021-01596-3. Epub 2021 Oct 30.

DOI:10.1038/s41416-021-01596-3
PMID:34718356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8727631/
Abstract

BACKGROUND

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with poor prognosis. By performing multiomic profiling, we recently uncovered super-enhancer heterogeneity between breast cancer subtypes. Our data also revealed TCOF1 as a putative TNBC-specific super-enhancer-regulated gene. TCOF1 plays a critical role in craniofacial development but its function in cancer remains unclear.

METHODS

Overall survival and multivariant Cox regression analyses were conducted using the METABRIC data set. The effect of TCOF1 knockout on TNBC growth and stemness was evaluated by in vitro and in vivo assays. RNA-seq and rescue experiments were performed to explore the underlying mechanisms.

RESULTS

TCOF1 is frequently upregulated in TNBC and its elevated expression correlates with shorter overall survival. TCOF1 depletion significantly inhibits the growth and stemness of basal-like TNBC, but not of mesenchymal-like cells, highlighting the distinct molecular dependency in different TNBC subgroups. RNA-seq uncovers several stem cell molecules regulated by TCOF1. We further demonstrate that KIT is a downstream effector of TCOF1 in mediating TNBC stemness. TCOF1 expression in TNBC is regulated by the predicted super-enhancer.

CONCLUSIONS

TCOF1 depletion potently attenuates the growth and stemness of basal-like TNBC. Expression of TCOF1 may serve as a TNBC prognostic marker and a therapeutic target.

摘要

背景

三阴性乳腺癌(TNBC)是一种预后较差的侵袭性乳腺癌亚型。通过进行多组学分析,我们最近发现乳腺癌亚型之间存在超级增强子异质性。我们的数据还揭示了 TCOF1 是一种假定的 TNBC 特异性超级增强子调控基因。TCOF1 在颅面发育中发挥着关键作用,但它在癌症中的功能尚不清楚。

方法

使用 METABRIC 数据集进行总生存和多变量 Cox 回归分析。通过体外和体内实验评估 TCOF1 敲除对 TNBC 生长和干性的影响。进行 RNA-seq 和挽救实验以探索潜在的机制。

结果

TCOF1 在 TNBC 中频繁上调,其表达水平升高与总生存期缩短相关。TCOF1 耗竭显著抑制基底样 TNBC 的生长和干性,但对间质样细胞没有影响,这突出了不同 TNBC 亚组中分子依赖性的明显差异。RNA-seq 揭示了 TCOF1 调控的几个干细胞分子。我们进一步证明 KIT 是 TCOF1 介导 TNBC 干性的下游效应物。TNBC 中 TCOF1 的表达受预测超级增强子的调控。

结论

TCOF1 耗竭可有效减弱基底样 TNBC 的生长和干性。TCOF1 的表达可以作为 TNBC 的预后标志物和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/dc5f57b5ae02/41416_2021_1596_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/266fd422685a/41416_2021_1596_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/a6b1ddef8b3f/41416_2021_1596_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/099aa5513915/41416_2021_1596_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/4e4ce847a688/41416_2021_1596_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/dc5f57b5ae02/41416_2021_1596_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/266fd422685a/41416_2021_1596_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/a6b1ddef8b3f/41416_2021_1596_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/099aa5513915/41416_2021_1596_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/4e4ce847a688/41416_2021_1596_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b4/8727631/dc5f57b5ae02/41416_2021_1596_Fig5_HTML.jpg

相似文献

1
TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis.三阴性乳腺癌中 TCOF1 的上调促进了肿瘤干细胞特性和肿瘤生长,并与不良预后相关。
Br J Cancer. 2022 Jan;126(1):57-71. doi: 10.1038/s41416-021-01596-3. Epub 2021 Oct 30.
2
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.MCT-1/miR-34a/IL-6/IL-6R 信号轴促进三阴性乳腺癌中的 EMT 进展、癌症干性和 M2 巨噬细胞极化。
Mol Cancer. 2019 Mar 18;18(1):42. doi: 10.1186/s12943-019-0988-0.
3
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.EP300 敲低降低三阴性乳腺癌中的癌症干细胞表型、肿瘤生长和转移。
BMC Cancer. 2020 Nov 10;20(1):1076. doi: 10.1186/s12885-020-07573-y.
4
Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.鉴定与三阴性乳腺癌中 BET 抑制相关的干性相关基因谱。
Cell Oncol (Dordr). 2020 Jun;43(3):431-444. doi: 10.1007/s13402-020-00497-6. Epub 2020 Mar 12.
5
Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer.集成机器学习算法鉴定 KIF15 为三阴性乳腺癌的一个潜在预后生物标志物,并与干性相关。
Sci Rep. 2024 Sep 13;14(1):21449. doi: 10.1038/s41598-024-72406-y.
6
JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway.NFYA 激活 JARID2 通过 PI3K/AKT 通路促进三阴性乳腺癌细胞的干性。
Expert Rev Anticancer Ther. 2024 Oct;24(10):1029-1040. doi: 10.1080/14737140.2024.2394167. Epub 2024 Sep 10.
7
Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.较高水平的基质金属蛋白酶组织抑制因子-1(TIMP-1)表达与三阴性乳腺癌的不良预后相关。
Mol Cancer. 2016 Apr 30;15(1):30. doi: 10.1186/s12943-016-0515-5.
8
BTF3 promotes stemness and inhibits TypeⅠInterferon signaling pathway in triple-negative breast cancer.BTF3 在三阴性乳腺癌中促进干性并抑制 TypeⅠ干扰素信号通路。
Biochem Biophys Res Commun. 2021 Jan 22;537:22-28. doi: 10.1016/j.bbrc.2020.12.060. Epub 2020 Dec 28.
9
STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.STAT3 诱导的 HLA-F-AS1 通过上调 TRABD 促进三阴性乳腺癌细胞的增殖和干性特征。
Bioorg Chem. 2021 Apr;109:104722. doi: 10.1016/j.bioorg.2021.104722. Epub 2021 Feb 10.
10
THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast Cancer.THOC2 和 THOC5 调节三阴性乳腺癌的干性和放射抵抗性。
Adv Sci (Weinh). 2021 Dec;8(24):e2102658. doi: 10.1002/advs.202102658. Epub 2021 Oct 27.

引用本文的文献

1
[Enriching plasma exosomes for proteomic analysis using a phosphatidylserine-imprinted polymer].[使用磷脂酰丝氨酸印迹聚合物富集血浆外泌体用于蛋白质组学分析]
Se Pu. 2025 May;43(5):539-546. doi: 10.3724/SP.J.1123.2024.05003.
2
Targeting TUBB2B inhibits triple-negative breast cancer growth and brain-metastatic colonization.靶向TUBB2B可抑制三阴性乳腺癌的生长和脑转移定植。
J Exp Clin Cancer Res. 2025 Feb 17;44(1):55. doi: 10.1186/s13046-025-03312-y.
3
FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancer.

本文引用的文献

1
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease.108600 同时抑制 CK2/TNIK/DYRK1,抑制三阴性乳腺癌干细胞和化疗耐药性疾病。
Nat Commun. 2021 Aug 3;12(1):4671. doi: 10.1038/s41467-021-24878-z.
2
ANLN Enhances Triple-Negative Breast Cancer Stemness Through TWIST1 and BMP2 and Promotes its Spheroid Growth.ANLN通过TWIST1和BMP2增强三阴性乳腺癌干性并促进其球体生长。
Front Mol Biosci. 2021 Jul 1;8:700973. doi: 10.3389/fmolb.2021.700973. eCollection 2021.
3
Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling.
FOSL1 是一个关键调节因子,它驱动三阴性乳腺癌中 TCOF1 的表达,该表达受超级增强子调控。
Epigenetics Chromatin. 2024 Nov 10;17(1):34. doi: 10.1186/s13072-024-00559-1.
4
ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathway.ACAT1通过AKT/GSK3β/c-Myc信号通路促进膀胱癌的增殖和转移。
J Cancer. 2024 Apr 23;15(11):3297-3312. doi: 10.7150/jca.95549. eCollection 2024.
5
Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment.核糖体病基因作为癌症治疗药物靶点的潜力。
J Pharm Anal. 2024 Mar;14(3):308-320. doi: 10.1016/j.jpha.2023.10.001. Epub 2023 Oct 13.
6
TCOF1 promotes the colorectal cancer progression by stabilizing β-catenin.TCOF1 通过稳定 β-catenin 促进结直肠癌的进展。
Med Oncol. 2023 Nov 7;40(12):348. doi: 10.1007/s12032-023-02218-z.
7
HnRNPAB is an independent prognostic factor in non‑small cell lung cancer and is involved in cell proliferation and metastasis.异质性核糖核蛋白A/B是非小细胞肺癌的一个独立预后因素,且参与细胞增殖和转移。
Oncol Lett. 2023 Apr 12;25(6):215. doi: 10.3892/ol.2023.13801. eCollection 2023 Jun.
8
The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma.基于超级增强子相关基因的综合分析用于预测低级别胶质瘤患者的不同亚型和预后。
Front Genet. 2023 Apr 7;14:1085584. doi: 10.3389/fgene.2023.1085584. eCollection 2023.
9
A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma.一种用于预测肝细胞癌总生存期的癌症干细胞相关基因特征。
Front Genet. 2022 Sep 12;13:888601. doi: 10.3389/fgene.2022.888601. eCollection 2022.
10
Treacle is Upregulated in Cancer and Correlates With Poor Prognosis.在癌症中,Treacle表达上调且与预后不良相关。
Front Cell Dev Biol. 2022 Jun 20;10:918544. doi: 10.3389/fcell.2022.918544. eCollection 2022.
通过多组学分析定义三阴性乳腺癌中的超级增强子景观。
Nat Commun. 2021 Apr 14;12(1):2242. doi: 10.1038/s41467-021-22445-0.
4
Selection of DNA-encoded chemical libraries against endogenous membrane proteins on live cells.在活细胞上针对内源性膜蛋白的 DNA 编码化学文库的选择。
Nat Chem. 2021 Jan;13(1):77-88. doi: 10.1038/s41557-020-00605-x. Epub 2020 Dec 21.
5
A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.一种基于片段的通用方法,用于鉴定和优化靶向RNA的生物活性配体。
Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33197-33203. doi: 10.1073/pnas.2012217117. Epub 2020 Dec 14.
6
Targeting cancer stem cell pathways for cancer therapy.针对癌症干细胞通路的癌症治疗。
Signal Transduct Target Ther. 2020 Feb 7;5(1):8. doi: 10.1038/s41392-020-0110-5.
7
Epigenetic therapy inhibits metastases by disrupting premetastatic niches.表观遗传学治疗通过破坏前转移龛来抑制转移。
Nature. 2020 Mar;579(7798):284-290. doi: 10.1038/s41586-020-2054-x. Epub 2020 Feb 26.
8
JASPAR 2020: update of the open-access database of transcription factor binding profiles.JASPAR 2020:转录因子结合谱开放获取数据库的更新。
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92. doi: 10.1093/nar/gkz1001.
9
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.三阴性乳腺癌:当前认识与针对癌症干性的未来治疗突破
Cancers (Basel). 2019 Sep 9;11(9):1334. doi: 10.3390/cancers11091334.
10
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.三阴性乳腺癌化疗耐药的机制——我们如何应对挑战。
Cells. 2019 Aug 22;8(9):957. doi: 10.3390/cells8090957.